THE BURDEN OF ICS/LABA-TREATED ASTHMA PATIENTS IN THE UK ADULT POPULATION

被引：3
|
作者：
Price, D. [1 ]
Mathieson, N. [2 ]
Mulgirigama, A. [2 ]
Scowcroft, A. [2 ]
Pedersini, R. [3 ]
Isherwood, G. [3 ]
Pavord, I. D. [4 ]
机构：
[1] Univ Aberdeen, Acad Ctr Primary Care, Aberdeen, Scotland
[2] Boehringer Ingelheim Ltd UK, Bracknell, Berks, England
[3] Kantar Hlth, Epsom, Surrey, England
[4] Univ Hosp Leicester NHS Trust, Inst Lung Hlth, Glenfield Hosp, Leicester, Leics, England
来源：
THORAX | 2013年 / 68卷
关键词：
D O I：
10.1136/thoraxjnl-2013-204457.167
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：A82 / A82
页数：1
相关论文
共 50 条
  • [1] Burden of asthma among patients adherent to ICS/LABA: A real-world study
    Davis, Jill
    Trudo, Frank
    Siddall, James
    Small, Mark
    JOURNAL OF ASTHMA, 2019, 56 (03) : 332 - 340
  • [2] The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review
    Czira, Alexandrosz
    Martin, Amber
    Turner, Monica
    Meeraus, Wilhelmine
    Birch, Helen
    Zhang, Shiyuan
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [3] EVELUT®: dyspnoea and symptom burden in COPD patients switching from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Buhl, R.
    Dreher, M.
    Mattiucci-Guehlke, M.
    Eckhardt, S.
    Taube, C.
    Vogelmeier, C.
    Buhl, R.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [4] Suboptimally controlled asthma in patients treated with inhaled ICS/LABA: prevalence, risk factors, and outcomes
    Shiyuan Zhang
    John White
    Alyssa Goolsby Hunter
    David Hinds
    Andrew Fowler
    Frances Gardiner
    David Slade
    Sharanya Murali
    Wilhelmine Meeraus
    npj Primary Care Respiratory Medicine, 33
  • [5] Suboptimally controlled asthma in patients treated with inhaled ICS/LABA: prevalence, risk factors, and outcomes
    Zhang, Shiyuan
    White, John
    Hunter, Alyssa Goolsby
    Hinds, David
    Fowler, Andrew
    Gardiner, Frances
    Slade, David
    Murali, Sharanya
    Meeraus, Wilhelmine
    NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2023, 33 (01)
  • [6] The MiSTIC Study Design: Medium Strength Triple Therapy Vs High Strength ICS/LABA for Adult Patients With Asthma Uncontrolled on Medium Strength ICS/LABA
    Kostikas, K.
    Topole, E.
    Singh, D.
    Brusselle, G. G.
    Kots, M.
    Vele, A.
    Georges, G.
    Papi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [7] THE ECONOMIC BURDEN OF ADULT ASTHMA THAT IS UNCONTROLLED ON MEDIUM-TO-HIGH-DOSE ICS-LABA: A SYSTEMATIC LITERATURE REVIEW
    Czira, A.
    Martin, A.
    Turner, M.
    Meeraus, W.
    Birch, H.
    Zhang, S.
    VALUE IN HEALTH, 2020, 23 : S729 - S729
  • [8] Comparative Adherence of ICS/LABA Products in Elderly Asthma Patients
    Tadrous, Mina
    Martins, Diana
    Yao, Zhan
    Stanbrook, Matthew
    Singh, Samantha
    Juurlink, David N.
    Mamdani, Muhammad M.
    Gomes, Tara
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 488 - 489
  • [9] Efficacy and Safety of High ICS Dose Fixed-Combination ICS/LABA/LAMA pMDI Compared with ICS/LABA and ICS/LABA plus LAMA in Patients with Uncontrolled Asthma: The TRIGGER Study
    Canonica, G. W.
    Virchow, J.
    Kots, M.
    Zuccaro, F.
    Carzana, E.
    Vele, A.
    Georges, G.
    Petruzzelli, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [10] Pneumonia in COPD patients treated with fixed ICS/LABA combinations
    Janson, Christer
    Larsson, Kjell
    Lisspers, Karin
    Stallberg, Bjorn
    Stratelis, Georgios
    Telg, Gunilla
    Jorgensen, Leif
    Johansson, Gunnar
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345